Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 321.15 DKK 0.45% Market Closed
Market Cap: 1.4T DKK

Wall Street
Price Targets

NOVO B Price Targets Summary
Novo Nordisk A/S

There are no price targets for NOVO B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Novo Nordisk A/S Competitors:
Price Targets
VIRP
Virbac SA
20% Upside
1681
Consun Pharmaceutical Group Ltd
30% Upside
600750
Jiang Zhong Pharmaceutical Co Ltd
19% Upside
ALKEM
Alkem Laboratories Ltd
6% Upside
4568
Daiichi Sankyo Co Ltd
70% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
14% Upside

Revenue
Forecast

Revenue Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 3 years is 6%.

12%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 3 years is 1%.

15%
Past Growth
1%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Novo Nordisk A/S

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 3 years is 4%.

15%
Past Growth
4%
Estimated Growth
Estimates Accuracy
8%
Average Beat
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NOVO B's stock price target?
Not Available

NOVO B doesn't have any price targets made by Wall Street professionals.

What is Novo Nordisk A/S's Revenue forecast?
Projected CAGR
6%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's revenue is 12%. The projected CAGR for the next 3 years is 6%.

What is Novo Nordisk A/S's Operating Income forecast?
Projected CAGR
1%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's operating income is 15%. The projected CAGR for the next 3 years is 1%.

What is Novo Nordisk A/S's Net Income forecast?
Projected CAGR
4%

For the last 13 years the compound annual growth rate for Novo Nordisk A/S's net income is 15%. The projected CAGR for the next 3 years is 4%.

Back to Top